The report “Medical Elastomers Market by Type (Thermoset and Thermoplastic), Application (Medical Tubes, Catheters, Syringes, Gloves, Medical Bags, and Implants), and Region (North America, Europe, APAC, MEA, and South America) Global Forecast to 2022” The medical elastomers industry is projected to reach USD 7.92 Billion by 2022, at a CAGR of 7.5% between 2017 and 2022. The medical elastomers market is projected to grow from USD 5.51 Billion in 2017 to USD 7.92 Billion by 2022, at a CAGR of 7.5% from 2017 to 2022. The growth of the market is attributed to rising demand for medical devices across the globe. Increased awareness among governments to provide high-quality healthcare infrastructure is also expected to drive the market for medical devices. This will, in turn, grow the medical elastomers market across the globe.
To Remain ‘ahead’ of Your Competitors, Request for a Sample@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=191173877
The medical tubes segment is projected to lead the medical elastomers market during the forecast period.
Based on application, the medical tubes segment accounted for the largest share of the medical elastomers market in 2017. The growth of this application segment is attributed to the increasing use of medical tubes in the diagnosis and treatment of diseases such as diabetes and cancer. Medical elastomers are increasingly used in the manufacturing of medical tubes owing to their low cost, bio durability, biocompatibility, and easy availability.
The thermoplastic segment is the largest and the fastest-growing type segment of the medical elastomers market.
Based on type, the thermoplastic segment of the medical elastomers market is projected to grow at the highest CAGR between 2017 and 2022. This segment is also expected to lead the market during the forecast period. The growth of thermoplastic elastomers is attributed to their low cost, bio durability, biocompatibility, transparency, and high microbial stability, which are ideal properties in the manufacturing of medical devices.
APAC is the fastest-growing market for medical elastomers.
The APAC region is the fastest-growing market for medical elastomers across the globe. The growth of the APAC medical elastomers market can be attributed to the growing population and increasing healthcare expenditure of countries in this region. In APAC, the demand for medical elastomers is majorly driven by emerging economies, such as Indonesia, Japan, China, and India. The increased use of single-use medical devices, such as catheters, medical tubes, gloves, and syringes, is also expected to drive the growth of the APAC medical elastomers market during the forecast period.
For any Queries Linked with the Report, Ask an Analyst@ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=191173877
Most active players in the medical elastomers market
BASF SE (Germany), DowDuPont (US), Eastman Chemical Company (US), Royal DSM (Netherlands), Solvay S.A. (Belgium), Trelleborg AB (Sweden), Momentive Performance Materials Inc. (US), Celanese Corporation (US), PolyOne Corporation (US), Teknor Apex (US), and Kuraray Co. Ltd. (Japan) are some of the leading players operating in the medical elastomers market.
This research report categorizes the medical elastomers market based on type, application, and region. Based on type, the medical elastomers market has been segmented into thermoset and thermoplastic elastomers. Based on application, the market has been segmented into medical tubes, catheters, gloves, syringes, medical bags, implants, and others. The geographic analysis of the medical elastomers market includes regions such as North America, APAC, Europe, South America, and the Middle East & Africa.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.